Evidence map›Paper›PMID 34056131›Full record

ReviewRomanian journal of anaesthesia and intensive care2020

Biomarkers in Cystic Fibrosis Lung Disease - A Review.

Ioana Mihaiela Ciuca, Paula Marian, Marc Monica

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Romanian journal of anaesthesia and intensive care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 69% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ioana Mihaiela CiucaPediatric Department, University of Medicine and Pharmacy "Victor Babes" Timisoara, Timisoara Romania.
Paula MarianDepartment of Medical Disciplines , Oradea University, Faculty of Medicine and Pharmacy, Oradea, Romania.
Marc MonicaPulmonology Department, University of Medicine and Pharmacy "Victor Babes" Timisoara, Timisoara Romania.
Victor Babeș University of Medicine and Pharmacy Timișoara · ROUniversity of Oradea · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic fibrosis is a polymorphic disease, marked by multiple and difficult-to-treat respiratory exacerbations with severe evolution. The lung disease dictates the disease's evolution and it must be diagnosed early and treated accordingly, but the diagnosis is sometimes challenging because of the lack of a sensible tool. In the era of the biomarkers, the need for a sensitive and reliable one would be extremely important, considering that inflammation secondary to infections produce irreversible structural changes in the cystic fibrosis lungs. The present paper reviews the studied biomarkers in inflammation and infection with potential role in cystic fibrosis lung disease.

Indexed as

biomarkerschildrenCystic fibrosis lung disease

Identifiers

PMID34056131
PMCPMC8158324
OpenAlexW3164399785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.